Document Detail


Hepatic stimulator substance mitigates hepatic cell injury through suppression of the mitochondrial permeability transition.
MedLine Citation:
PMID:  20136651     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hepatic stimulator substance (HSS) has been shown to protect liver cells from various toxins. However, the mechanism by which HSS protects hepatocytes remains unclear. In this study, we established BEL-7402 cells that stably express HSS and analyzed the protective ability of HSS on cells through mitochondrial permeability (MP). After administration of carbonyl cyanide m-chlorophenylhydrazone (CCCP), a specific agent that leads to depolarization of the mitochondrial transmembrane potential, the apoptosis rate of HSS-expressing cells was significantly reduced, as measured using Hoechst staining and flow cytometry. The mitochondrial membrane transition and cytochrome c leakage were significantly inhibited in the HSS-expressing cells as compared with the untransfected cells, and, as a consequence, the cellular ATP content in the HSS-expressing cells was relatively preserved. Additionally, decreased caspase-3 activity was observed in the HSS-expressing cells treated with CCCP as compared with the vector-transfected cells and cells expressing mutant HSS. Furthermore, silencing of HSS expression using small interfering RNA accelerated CCCP-induced apoptosis. In isolated mitochondria, recombinant HSS reduced the release of cytochrome c induced by CCCP, indicating a possible role for HSS in regulation of mitochondrial permeability transition (MPT). HSS-expressing BEL-7402 cells are resistant to CCCP injury, and HSS protection is identical to that observed with cyclosporin A, an inhibitor of MPT. Therefore, we propose that the protective effect of HSS may be associated with blockade of MPT.
Authors:
Yuan Wu; Jing Zhang; Lingyue Dong; Wen Li; Jidong Jia; Wei An
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-02-03
Journal Detail:
Title:  The FEBS journal     Volume:  277     ISSN:  1742-4658     ISO Abbreviation:  FEBS J.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-04-15     Completed Date:  2010-05-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101229646     Medline TA:  FEBS J     Country:  England    
Other Details:
Languages:  eng     Pagination:  1297-309     Citation Subset:  IM    
Affiliation:
Department of Cell Biology and Municipal Key Laboratory for Liver Protection and Regulation of Regeneration, Capital Medical University, Beijing, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology
Apoptosis / drug effects
Carbonyl Cyanide m-Chlorophenyl Hydrazone / pharmacology
Cell Line
Flow Cytometry
Gene Expression Regulation
Liver / cytology,  injuries
Mitochondria, Liver / metabolism*
Peptides* / genetics,  metabolism,  pharmacokinetics
Permeability / drug effects
Recombinant Proteins / genetics,  metabolism,  pharmacokinetics
Reverse Transcriptase Polymerase Chain Reaction
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Peptides; 0/Recombinant Proteins; 0/hepatic stimulator substance; 555-60-2/Carbonyl Cyanide m-Chlorophenyl Hydrazone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Random forest can predict 30-day mortality of spontaneous intracerebral hemorrhage with remarkable d...
Next Document:  Developmental consequences of alternative Bcl-x splicing during preimplantation embryo development.